Impact of Genetic Sequencing for Rare Disease Diagnosis

20 February 2020

In the search for a rare disease diagnosis, whole genome sequencing has the opportunity to provide answers earlier and can make a difference in care.

Interested in learning about how a panomics-based drug discovery approach is fueling novel diagnostic and therapuetic targets for common chronic diseases? Read this article


Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on